private chemotherapy treatment - Woman receiving cancer chemotherapy

Who Was The First Ever Person Treated With Chemotherapy?

The first treatment for cancer that comes to mind to people who are not necessarily familiar with oncology is chemotherapy, and private chemotherapy treatment is not only highly effective but also focuses on ensuring a high quality of life before, during and after the course is complete.

There are a lot of different types of chemotherapy, but they work by using particular treatment agents to inhibit the growth or damage the DNA of cancerous cells, which is taken in cycles to break down and kill a cancerous tumour.

It can be undertaken on its own or in combination with radiotherapy to enhance its effect, radiosurgery or conventional surgery to kill any existing cancer cells following the destruction or excision of the tumour.

There are countless chemotherapy treatments and the right one for you will depend in large part on the type of cancer you have, its current progression, your overall health and your personal wishes when it comes to how you want to be treated. We are there every step of the way.

It is the newest of the three most established treatment pathways for cancer, with surgery and radiotherapy respectively being technically older but having changed significantly in the century since they were first used.

Chemotherapy was the result of an accidental discovery of a beneficial side effect of a chemical agent designed to cause harm.

The Development Of Chlormethine

The beginning of chemotherapy begins with the ancestor of chlormethine, a specialist drug that is either injected or used topically to treat certain types of skin cancers such as lymphoma, polycythaemia vera and some types of lung cancer.

Chlormethine, sometimes known as Mustargen, was originally derived from a much more harmful compound designed not to treat cancer but to cause harm: mustard gas.

Initially discovered in the 1860s by Frederick Guthrie, it was manufactured by Franz Haber and used in the First World War as one of the first modern chemical weapons ever deployed.

Whilst the harm mustard gas caused was immeasurable, and it was first banned in 1925 for that reason, there was also a rather interesting side effect found that it could also kill cancer cells in the lymph nodes in studies on its physiological effects.

The phenomenon was first discovered in 1919 by Dr Edward Krumbhaar, but it was not until the 1940s that these findings were fully applied to the treatment of cancer.

Early studies in mice, later confirmed in rabbits with lymphoma, confirmed its potential therapeutic properties once the sulphur used to make mustard gas was replaced with the less volatile nitrogen to create nitrogen mustard, which would become chlormethine.

Patient JD

The first human patient to ever be treated with chemotherapy was a man known as JD, living in Connecticut having been born in Poland.

Born in 1894, he emigrated to the United States and worked in a factory that manufactured ball bearings until he became ill in 1940 with non-Hodgkin lymphoma, then described as lymphosarcoma.

It was particularly aggressive, causing swelling throughout the right side of his neck, requiring 16 consecutive days of external beam radiotherapy using X-rays in 1941, before undergoing surgery to remove some of the tumours.

By 1942, the case had seemingly become terminal; the tumours were unresponsive to treatment, and the placement of the tumours made it particularly difficult to treat.

Out of options, JD’s doctors allowed for the use of chlormethine, known as “substance X” to ensure secrecy. This was the first use of chemotherapy to treat cancer, and the results were rather astonishing.

An unresponsive cancer had drastically reduced after five days, and despite struggling to breathe before the treatment, he found it easy to move his head and eat comfortably without difficulty. It had not only saved his life but given him his life back.

Unfortunately, whilst it was the right treatment, it was ultimately too late, and JD passed away 96 days following his first dose of treatment due to a relapse in the cancer at the age of 48.

A Legacy Of Lifesaving Care

JD’s story mirrors that of the unnamed 52-year-old patient of Victor Despeignes who in 1896 was the first person with cancer to be treated using X-rays. Once again, the treatment was remarkably effective but arrived too late to help.

Their bravery and willingness to try a treatment that was experimental at the time have contributed to the saving of millions of lives by proving the effectiveness of both treatments.

It led to the development of other chemotherapy medications, and within the decade following the Second World War, chemotherapy became an established treatment practice. By 1965 and the development of combination chemotherapy, cancer care was transformed forever.

Get in touch

Our team will guide you throughout every stage of your private chemotherapy treatment and ensure you’re comfortable during each visit. Contact us for more information.

Radiotherapy treatment - Patient Radiation therapy mask showing laser lines for targeting cancer cells in the brain

What Is Brachytherapy And When Is It Used To Treat Cancer?

Treating cancer using radiation therapy is about using precisely managed and targeted radioactivity to destroy malignant tissue whilst sparing healthy tissue surrounding it.

In some cases, this is undertaken using an external radiotherapy beam, such as with the Gamma Knife method. However, there are other cases where the most precise way to deliver doses of radiation is from within using brachytherapy.

Also known as internal radiation, brachytherapy is often used to provide high-dose radiotherapy safely and in a short space of time, but exactly when and where it is most appropriate to use it will often depend on the needs of an individual person and their particular diagnosis.

What Is Brachytherapy?

Brachytherapy uses a source of radiation placed close to the cancer or to where a cancerous tumour has been removed following surgery.

The name brachytherapy comes from the Greek word ‘brachys’, which means ‘short-distance’, and unlike external beam radiotherapy, which often has to pass through several layers of tissue and body matter before reaching a tumour, brachytherapy is placed close to or directly onto the cancer itself.

There are multiple forms of brachytherapy, but they are typically categorised as either high dose rate (HDR) or low dose rate (LDR) which are either temporarily applied or implanted in the body respectively.

HDR brachytherapy usually involves the use of an applicator tube or needle inserted into the body before a radioactive material travels towards it and remains there for as little as five minutes before returning to the source.

By contrast, LDR involves the implantation of radioactive seeds, discs or other tiny pieces of material typically smaller than a grain of rice. This is typically applied using wires or needles and can be either temporary or permanent depending on the type of treatment.

When Was Brachytherapy First Used?

Brachytherapy is the first practical form of radiotherapy, as whilst experimental treatments using X-rays were tried mere months after Wilhelm Roentgen’s discovery, the use of radioactive materials was suggested in 1901 by Pierre Curie.

The use of radioactive seeds, initially made from radium sulphate, was pioneered in the early 1900s thanks to the work of William Duane, and a very similar system of application is still used to this day.

Before the development of external-beam radiation, CT and MRI scans which allow modern forms of external radiotherapy to be accurate and safe, brachytherapy was the standard treatment path for several forms of cancer.

Whilst its uses are more specific today, it still has some advantages that make it a viable option for oncologists in certain cases.

What Are The Advantages Of Brachytherapy?

There are several advantages to using brachytherapy, both in HDR and LDR forms, as they can provide higher doses of radiation with a greater degree of flexibility or adaptation compared to some types of external beam radiotherapy treatment.

Brachytherapy is inherently localised; the radiation source is placed directly on the cancer or as close as possible, which means that healthy tissue is less exposed to radiation, reducing potential damage and recovery times.

This localisation can also reduce treatment times significantly; whilst some radiotherapy treatments can take several hours, brachytherapy can take as little as five minutes and typically takes no more than 20, which allows for multiple treatments per day or for a course to be completed more quickly.

As well as this, in cases where the tumour shifts position in the body, something that can be common with cancers that affect the digestive, urinary and reproductive systems, the radioactive implants will move with the cancer and stay in the same position.

Both of these elements reduce the ability of cancer cells to recover and multiply between treatment sessions, and this can sometimes mean that a treatment that would ordinarily require a patient to spend time in a hospital can be completed in an outpatient setting.

When Is It Used To Treat Cancer?

It is typically used to treat cancers within body cavities or close to the skin, with the most common treatments focusing on cancers of the cervix, prostate, skin and breast. The easier it is to access a tumour, the greater the chance that brachytherapy can be used.

Generally, it is used to treat early-stage cancer before it has a chance to spread or metastasise, as it is a well-known, advanced, safe and often painless procedure, or it can sometimes be used following other more intensive cancer treatments to destroy any lingering cancer cells.

Permanent low-dose seed implantation is a standard treatment for localised prostate cancer, as it is less invasive than other treatments and a person can return to normal in just a few days.

amethyst radiotherapy - nurse supporting woman battling cancer

What Side Effects Can You Expect from Radiotherapy?

Radiotherapy is used to treat all kinds of cancer. It uses radiation to destroy cancer cells by damaging the DNA of those cells. This radiation is targeted to the site of the tumour to cure or shrink the tumour. The aim is always to direct as much of the radiation as possible at the cancerous cells, with as little affecting the healthy cells surrounding it as possible.

However, while radiotherapy is a targeted treatment, it can still cause side effects in the healthy cells surrounding the cancer. The good news is that these side effects are typically localised to the area of treatment.

There are also some general side effects of radiotherapy to be aware of.

Tiredness

One of the most common side effects of radiotherapy is tiredness. There are many factors that can make you feel tired during your treatment, ranging from how stressed or anxious you feel about it to how far you have to travel for each treatment.

Of course, we can’t forget that your body is working hard to fight the cancer and this in itself can cause fatigue. Your body will also use energy to repair healthy cells following radiotherapy, all of which can contribute to you feeling more tired or lethargic than usual.

You may also find that you feel more tired as your treatment progresses. This is normal, although if you have any concerns you should discuss them with your doctor or radiotherapist.

There are some simple steps you can take to help alleviate your tiredness during your treatment. Drinking plenty of water and staying hydrated is important, as is eating a healthy and balanced diet.

Eating the right diet to support your body before, during and after treatment can minimise the side effects you experience as well as reduce the amount of time it takes you to recover once your course of radiotherapy has finished.

Changes to your eating habits

That said, radiotherapy can sometimes make it difficult for you to eat or drink, or it can make you feel nauseous. This side effect is most common in patients whose radiotherapy treatment is targeted at areas like the head, brain, neck or stomach.

Your radiotherapist will talk to you about the possibility of such side effects before you start your treatment and will ensure you have support to manage this as your course of radiotherapy progresses.

If you do find that eating is difficult during radiotherapy, concentrate on consuming high protein, high energy foods, such as meat, fish, eggs, pulses (like lentils and beans) and dairy products. This will help your body recover, even if you are eating less frequently or smaller amounts than usual.

Sore skin

You may experience soreness on your skin around the area of your treatment. In some cases the skin reddens and in others it can feel itchy or sore. You often won’t notice any skin reactions early in your treatment, but as your radiotherapy course continues they can appear.

It’s important to talk to your radiographer about any skin reactions you experience. In the vast majority of cases, the skin will recover within a few weeks of the treatment finishing. In the meantime, the best advice is to wear loose-fitting items of clothing made from natural fibres and to avoid rubbing the skin in the affected area.

You can still wash it with soap and water, but pat it dry carefully afterwards to avoid damaging the skin further.

What about hair loss?

Many people are concerned about hair loss during their cancer treatment. When you are having radiotherapy, hair loss is usually restricted to the site of the treatment. That means you will more than likely keep the hair on your head, unless this is where your radiotherapy is directed.

There is a chance that your hair may not regrow after your treatment finishes, but your doctor will discuss this with you along with the other side effects you may experience to help you cope and ensure you are prepared for what’s to come.

Emotional side effects

We also can’t overlook the emotional side effects of receiving a cancer diagnosis and going through treatment. These side effects are not restricted to undergoing radiotherapy and can surface at any point during your journey.

It’s important to talk about how you’re feeling both with your doctor and those closest to you. Feeling anxious or scared is normal. At Amethyst we offer psychological support to all of our patients to help them and their loved ones manage the emotional strain of fighting cancer.

Learn more about our advanced radiotherapy and support services on the Amethyst Group website.

Private radiotherapy - linear accelerator technology IMRT

How TrueBeam Radiotherapy Works to Treat Cancer

Cancer patients can be treated in a wide range of ways, but while it is usually the case that your treatment will involve a combination of different treatments, radiotherapy is commonly used as part of the treatment programme.

Whether you have had surgery to remove part or all of a tumour, are taking anti-cancer drugs or can benefit from gene therapy, there is still a good chance that you may need radiotherapy. Moreover, there are different kinds of radiotherapy and the specific type that is best for you may vary.

Patients who are not familiar with radiotherapy, such as those in the early stages of treatment or who have not had a close family member experience it, may be unaware of just how many types there are and what each of them is used for.

However, it can be very beneficial to know more to help make informed decisions about private radiotherapy treatment options, which you can do with our oncologists. Among them is when, or if, you could benefit from TrueBeam Radiotherapy.

What Is TrueBeam Radiotherapy?

TrueBeam Radiotherapy is one of the latest and most advanced forms of radiotherapy that exists. Many treatments that are still used today involve radiation that covers a larger area of the body (such as that delivered through a linear accelerator) or are even taken internally, such as an injected radioactive substance, which means they are not delivered so precisely.

What TrueBeam radiotherapy does is advance a technique known as stereotactic radiosurgery, where a beam of intense radiation can be aimed at a very specific point, such as a tumour, to have maximum effect in shrinking the tumour while minimising exposure of surrounding tissue.

This is especially useful in locations such as the brain, where the consequences of damage to surrounding areas would be severe, but it applies to other parts of the body too, where organ damage could have major consequences.

How TrueBeam takes this further is in the way it combines the technology to produce very precise beams of radiation with 3D imaging and motion management technology, which can provide not just still images to show exactly where best the beam should be aimed, but real-time tracking and guidance to deal with moving targets.

Such precision can be measured in fractions of millimetres, while the guidance enables the beam to avoid vital organs, including the heart, as well as areas of brain tissue when tackling tumours of the brain, neck and head.

All Over In Three Minutes

Not only does such precision enable the target to be hit with pinpoint accuracy, but also for the whole process to be completed very quickly. Just two or three minutes can be enough, compared to a period of up to half an hour that might have been used in the past.

Faster treatment means there is less physical movement by the patient, which adds to the accuracy and reduces the side effects further.

There are several specific kinds of cancer that TrueBeam is useful for tackling. The most obvious is brain cancer, as precise targeting of tumours with minimal exposure of healthy brain tissue to radiation is essential. But it can also be used effectively against tumours of the spine, liver, prostate, lung and gastrointestinal system.

In each of these cases, there will be other organs close by that might be adversely affected by exposure to radiation, while the organs themselves may be small (such as the prostate) and therefore the tumours likewise present a target requiring very accurate targeting.

This does not mean that your treatment, while short, will not produce side effects. These include fatigue, skin irritation, hair loss and stomach upsets. These are all common side effects for patients undergoing any form of radiotherapy.

TrueBeam radiotherapy is very unlikely to be used as the only form of treatment you undergo. As with any other form of radiotherapy, it is likely to be used in conjunction with surgery to excise the tumour, chemotherapy and more.

When Is TrueBeam Right For You?

The characteristics of this technology mean it is calibrated for certain conditions, and by the same token, that makes it unsuitable for some other conditions, such as secondary cancer that exists in multiple places, which would not be best targeted by a precision beam aimed at single, precise points.

What this shows is that when it comes to getting radiotherapy treatment, it helps to be aware that there are different kinds of treatment and some are more suited to certain circumstances than others. Research and technological development have produced many innovations, including TrueBeam, with more no doubt sure to come.

If you have one of the cancers mentioned above, speak to us about your treatment options. It may be that TrueBeam is suitable for treating your condition.

Learn more about our advanced radiotherapy treatments for different cancers on the Amethyst Group website.

Private radiotherapy - Woman with cancer during chemotherapy

How Radiotherapy Aids in Improving Cancer Survival Rates

When private radiotherapy was first used to treat cancer patients in the early 20th century, it was as a means of palliative care to ease the suffering of the dying. While it is still often used this way today, for most of the past century, it has also had a role in extending life and, in some cases, defeating cancer altogether.

Outcomes for patients will depend on a range of factors, from the type of cancer to age and, most importantly, how early the cancer is diagnosed. Nonetheless, two factors have become increasingly prevalent in recent years. One is that there are more diagnoses, while the other is an increase in successful treatments.

Cancer Rates Up – But So Is Survival

The latest UK data has highlighted this. Cancer Research UK’s Cancer in the UK report, published this month, revealed that over the past 50 years, the proportion of people in Britain being diagnosed with cancer has risen by 47 per cent. However, the mortality rate has fallen by 22 per cent over the same period.

Most notably, the proportion of people who get cancer but survive at least another ten years is now one in two, compared with one in four in the early 1970s.

The diagnostic element is an important factor, as better and earlier detection is important in tackling cancer, in particular by treating it before metastasis takes place – the point at which cancer cells break away from the area initially affected and migrate to other parts of the body.

At the same time, there are other reasons for an increase in diagnoses, not least an ageing population.

The Global Picture

The UK situation is anything but unique. Survival rates are improving around the world thanks to improved diagnostics, but also more advanced treatments. Indeed, data published by the World Population Review has shown that some countries are outperforming Britain, and indeed other Western countries, in many areas.

For example, the highest five-year survival rates for stomach cancer are to be found in South Korea, followed by Japan and Jordan. Europe is also outperformed by Japan, the US and others in lung cancer survival. However, in breast cancer, the survival rate in most European countries is over 80 per cent. Prostate cancer survival rates are higher still.

Across the globe, these figures will be much more favourable than they were not just half a century ago, but more recently. Moreover, while ageing populations and advances in diagnostics make higher case rates likely in the coming years, survival rates can be expected to continue to improve as new and better treatments emerge.

The Role Radiotherapy Plays In Better Outcomes

The improvements in treatment have certainly not all come from radiotherapy, with other kinds of therapy and new drugs emerging with great regularity. Nonetheless, the advancement in the use of radiotherapy has made a huge difference.

This has included the use of more focused stereotactic radiosurgery that can target precise areas such as tumours without harming sensitive surrounding tissue (a particular priority in brain cancer cases), plus the advancement in scanning techniques to enable better targeting and monitoring of the delivery of radiation.

Further benefits can arise when the calibration of doses is aided by technological advances and research indicating how high (or low) a dosage may be beneficial in various circumstances, through a better understanding of the balance between the benefits of treating the cancer and any associated side-effects of treatment.

Austrian Research Offers Lung Cancer Breakthrough

Among the very latest developments has been research showing that high-dose radiation therapy can improve prospects for lung cancer patients without increasing the risk to the patient. This was the conclusion of a study run by Karl Landsteiner University of Health Sciences, in the Austrian city of Krems, the journal Cure Today reports.

Pulmonologist Dr Felix Schragel explained that the postulated risk was that higher doses of radiation might lead to more pneumonitis cases, which manifests in the form of dangerous lung inflammation. However, the study showed that patients given higher doses actually had lower rates of pneumonitis.

Furthermore, the data indicated a higher survival rate for lung cancer patients given the higher dose, with a 93 per cent one-year survival rate for those who had the higher dose, which remained steady after four years.

This research could help improve outcomes for patients with lung cancer when undergoing radiotherapy treatment. In the same way, patients with brain, prostate, breast, neck and other cancers may similarly benefit from other recent – and future – advancements in treatment.

Radiotherapy is not new, but the understanding of how best to deploy it and the technology to deliver it in the right amounts and precise locations are continuing to advance. In using the latest technology and insights, we aim to get the best possible outcome for every patient.

Learn more about our advanced radiotherapy treatments for different cancers on the Amethyst Group website.

chemotherapy - IV drip attached to young male patient's hand during chemotherapy

How Should You Prepare Before Your Chemotherapy Treatment?

The most successful treatments for cancer involve a tailored treatment plan based on the most up-to-date medical research on treating the particular type of cancer, but they also require a focus on the broader aspects of mental, physical and social health.

This is particularly true for chemotherapy treatment, due to the variable lengths of treatment and the broad differences in how people feel between the different rounds of treatment.

This, alongside the varying lengths of chemotherapy treatments themselves means that an effective treatment will focus not only on killing cancer cells but providing tailored support for someone throughout their entire treatment journey.

If your specialist treatment plan involves the use of chemotherapy, either as a primary treatment or in combination with radiotherapy, here are some ways that you can get ready for treatment and make it easier to manage.

Ask Your Team About What To Expect

Your cancer team, including your lead doctor and nurse, will provide clear, helpful answers to any questions you may have about your treatment, and what they will say about the practical aspects of cancer care will often shape the types of preparations you may need to make.

They will often provide straightforward advice for managing cancer treatment, but the most important question to ask is about how the chemotherapy drugs will be administered, how long it will take, and whether they are affected by other medications you are taking or may take in the future.

If the infusions will take hours, days or weeks, you may need to pack a chemotherapy bag with essentials, changes of clothing and entertainment to pass the time.

Make Preparations For Fertility And Dental Health

Depending on where you are being treated, chemotherapy might have an effect on other parts of your overall health. Your cancer team will inform you of this and in some cases provide direct support through our holistic approach to cancer care.

In other cases, it may be important to have other medical work undertaken ahead of time, such as necessary dental work to avoid infection, storing eggs and sperm for future fertility or other options for preserving long-term health if it could be affected by the nature of the treatment.

Start A Healthy Living Routine

If you already have a workout and diet routine, it may be worth exploring how you can maximise your nutrition and physical health in preparation for cancer, as this can not only help with managing the effects of chemotherapy but also maintain your energy levels and mood.

This process is known as prehabilitation and many cancer teams will have dedicated physiotherapists and nutritionists to help provide advice, meal and workout plans tailored for and based around your treatment.

Because of the cyclical nature of chemotherapy, this routine is particularly important.

Discuss Your Situation With Work

Some people will work whilst undergoing cancer treatment, but it is important to discuss with your employer (or business stakeholders if you are self-employed) about your treatment and potential options for either taking medical leave or a reduction of hours.

Depending on where you live and local employment laws, your employer may be required to provide reasonable adjustments to enable you to keep working, such as flexible hours, additional breaks and time off so you can attend medical appointments.

Having this discussion ahead of time will enable you and your employer to manage your workloads and reduce any additional stress that could affect your treatment.

If you are unable to work during your treatment, there are various forms of financial support available, although the exact amounts and how to claim them can vary by region.

Make Sure You Have Day-To-Day Support On Standby

Because chemotherapy has spikes in intensity that the body recovers from, there will be days when you have a lot of energy and are able to do everything you want to or need to do, but on other days you might struggle to handle your day-to-day needs.

Exactly how chemotherapy will affect you depends on a wide range of factors, including your overall health and the treatment plan itself, but it is extremely beneficial for both your mental and physical health to talk to people you can trust and your cancer team about your practical needs.

Your friends, family, loved ones and neighbours will often be there to help with essentials such as having easy-to-cook meals, shopping, housework and personal care.

Having this available for your first session means you have fewer worries and can focus on relaxing, recovering and recuperating whilst the cancer treatment works.

Radiotherapy Centre - octor standing in front of the Z ray image

What Brain Tumour Awareness Month 2025 Has Taught Us

May has been Brain Tumour Awareness Month in multiple countries, which makes this a very good time to consider what progress has been made in developing the understanding and awareness of brain tumours, as well as advances in treatments.

When it comes to matters as serious as cancer, it really is relevant and important to understand how far we have come and what kinds of treatments exist. This is especially true if you or a loved one is a sufferer.

Of course, it can be easy to lose track of the themed days and months on the calendar, with a plethora of awareness days and months for various causes, many of them medical. Indeed, in the US, a type of brain tumour – Glioblastoma – has its own awareness day in July.

The US, Canada and Australia mark brain tumour awareness month in May, whereas the UK does so in March. In either case, this provides a very good opportunity to take stock of what has been discovered about tumours and also how they have been treated, as well as providing extra impetus (and funding) to research efforts around the world.

The Treatments We Have Now

The standard way to treat brain tumours is either excision by physical surgery or the use of radiotherapy. Sometimes a combination of both may be used. Patients coming to our radiotherapy centres may receive a range of different forms of treatment.

Among the different forms of radiotherapy for tumours is external beam radiotherapy, which involves directing a beam of radiation at the tumour from a source outside the body, usually using a linear accelerator machine.

The development of this treatment has not just been down to the invention and subsequent fine-tuning of the linear accelerator itself, but accompanying technology such as MRI and CT scans. This makes possible 3D conformal radiation therapy, where a 3D map of the tumour helps guide the delivery of the radiation.

Intensity modulated radiation therapy is a variation of this, where the strength of the radiation can be varied between different beams used in the treatment of a tumour. This is especially useful where the area targeted is closer to normal brain tissue, enabling the exposure of such tissue to harmful radiation to be minimised.

The Emergence Of The Gamma Knife

Another form of radiotherapy is stereotactic radiosurgery. This involves a particularly precise focus of the radiation beam on a specific area of the tumour.

This is commonly carried out with a gamma knife, which, despite its name, is not a knife but a device designed to produce a very concentrated beam of radiation, with the great benefit of minimising radiation exposure to surrounding tissue.

Radiotherapy has been used since the turn of the 20th century, but the gamma knife was a more recent development, which can be attributed to the Swedish neurosurgeon Lars Leksell, who patented it in 1967. A second version was produced in the 1970s as the technology improved, but this has been about fine-tuning a great device, not reinventing it.

In this context, it is useful to observe that there is already a huge amount that can be done to help patients with brain tumours, especially through radiotherapy, often through surgery and sometimes through other methods such as chemotherapy, although the latter is usually deployed in combination with other treatments rather than being used on its own.

What Are The Latest Advancements?

Nonetheless, an article published in the journal Cure Today has highlighted how new developments have further enhanced the power of radiotherapy to offer better treatments for patients with fewer side effects.

The article focused on a discussion to mark Brain Tumour Awareness Month in which Dr Ranjit Bindra, a professor at the Yale School of Medicine in the US, stated that proton therapy and image-guided precision have been major contributors to improvements in both areas.

He also noted that individualised and evidence-based cancer care can be made even better by close collaboration between all those involved, from neurosurgeons to radiation oncologists.

Positive news about developments such as proton therapy may also point the way towards a brighter future, with Dr Bindra striking an optimistic note about what further research can achieve, provided sufficient funding is available.

He commented: “As long as we maintain that funding, we will continue to make wonderful discoveries and change the lives of patients with brain cancer.”

Reasons To Be Positive

What this year’s Brain Tumour Awareness Month (be it March or May) has helped to highlight, therefore, is that radiotherapy continues to advance and deliver better outcomes with fewer side-effects for patients, with good reasons to expect further progress in the years ahead.

At Amethyst, we already use the best radiotherapy techniques and technology to seek optimal outcomes for patients, whether for brain tumours or other cancers. In the years to come, we may be able to do even more.

Learn more about our advanced radiotherapy treatments for brain tumours on the Amethyst Group website.

provide support and assistance - Woman doctor holding hands

What Mental Health Support Is Available During Radiotherapy?

From the moment you are diagnosed with cancer, every aspect of your care plays a role in ensuring that your cancer is destroyed and you make the best possible recovery as soon as possible.

This is why your multidisciplinary team will not only contain oncology experts from a wide variety of medical fields to ensure that you are provided the best courses of treatment possible that not only take your condition and the type of cancer into account but also your personal needs.

We take a particularly holistic approach to cancer treatment, and several members of the MDT are there to provide support and assistance at every step of your treatment, from the physical to the emotional.

Providing tailored psychological support is a critical aspect of care at all stages of the treatment process, and whether you need reassurance, coping strategies, or a sympathetic ear, mental health services are available.

How this will look for different people will vary somewhat, but here are some examples of the types of psychological support you can expect during your treatment journey.

When Diagnosed

One of the first parts of your treatment you are likely to receive will be mental health support following your diagnosis, because it is a lot for many people to take in so quickly.

Everyone has a slightly different reaction, but it is very common to feel shocked, angry or even feel nothing at first. It can be very difficult to process, especially at first, and oncological nurses and doctors will be sympathetic, open and transparent with your diagnosis and what comes next.

For many people, this is when mental health support is needed the most and a psychologist will be there to help you process in these early moments.

The connection between psychological care and your treatment is much closer than a lot of people realise, and we know that support during these early stages is not only essential for providing reassurances and help, but can potentially have an effect on physical symptoms and wellbeing during and following treatment.

Not everyone has the same needs at this early stage, however. Some people adjust to the diagnosis beyond the initial stage as preparations for treatment begin, whilst others will have appointments with a psychologist throughout the treatment process.

Much as there are hundreds of different types of cancers, there are many different avenues for support, and we are there at every stage to help.

During Treatment

Some people can adjust to the diagnosis, but the wait between the confirmation of the treatment plan and the preparations for the first treatment can leave some people feeling uneasy, and that is completely understandable.

Your MDT will explain the process, give you clear information on what to expect, and how you will feel, but until it happens, it is common to feel anxious.

Psychological support is there to help you with these practical concerns, but beyond this, they are also there to be a sympathetic listener for concerns you may not feel like you are able to voice elsewhere.

Cancer treatment can sometimes be intense and is not uncommon to have low energy levels, feel fatigued or struggle with day-to-day activities that were previously far easier. As advanced as modern cancer care is, it can still affect your quality of life and your relationship to your friends and family.

Your cancer team can help with medical and pharmacological solutions to some side effects, as well as provide advice regarding diet, exercise and resting.

Your support circle and cancer team are here for you throughout your treatment, and they will help you in every way they can.

Following Treatment

The weeks and months following cancer treatment can sometimes be difficult, particularly following a lengthy course of radiotherapy or chemotherapy, where the routine of going to see your radiotherapist, your oncologist and the other members of your cancer team has become so ingrained.

As with any intensive experience, it can take some time following the end of treatment to process and reflect, and it is okay not to be okay once the final course of treatment is over and you have been declared cancer free or the cancer is in remission.

Psychological care will continue to be available, and your cancer team will often signpost additional services, support groups and therapists who specialise in managing mental health post-cancer.

Support is always available, and people are always there for you even between follow-up appointments. It is okay to lean on that support whilst you recover and figure out what you want to do next, following treatment.

brachytherapy - family support

What Should You Expect During Brachytherapy Treatments?

There are several options available for treating tumours, but whilst the majority of radiotherapy treatments use an external source of radiation, brachytherapy implants a radiation source inside the body close to a tumour to destroy it from within.

It is most commonly associated with treatment for prostate or cervical cancer, although it has been used as part of breast, oesophageal, eye and skin cancers, as well as exceptionally rarely during the treatment of brain tumours.

Because a lot of people who receive treatment for cancer do so through some form of external beam radiotherapy (EBT), it can sometimes be difficult to know what to expect during internal brachytherapy.

Here are answers to some of the most common questions people have about internal radiotherapy.

Why Is Brachytherapy Used?

Brachytherapy is a highly accurate and precise set of treatments where radioactive material is placed in the body close to or directly inside the tumour in order to destroy it from within. This can either be temporary using a catheter or using radioactive seeds implanted next to the tumour.

These are known, respectively, as high-dose rate and low-dose rate brachytherapy.

As a primary cancer treatment, brachytherapy is primarily used to allow for higher doses of radiation to be applied to a target area without damaging healthy nearby tissue.

The principle is similar to the highly accurate external Gamma Knife treatment, although it can be applied in other places in the body besides the brain.

It can also be used as part of a combination treatment with external beam radiotherapy or surgery, although it is rare for brachytherapy to be combined with chemotherapy.

Brachytherapy is over 120 years old, and was one of the first versatile types of radiotherapy treatment, and is a proven, safe and effective treatment for a multitude of different types of cancer.

How Long Does Treatment Take?

One advantage of brachytherapy is that it does not require as many sessions as conventional external beam radiotherapy.

High-dose rate brachytherapy typically takes only one or two sessions because a much higher dose of radiation can be used per session, although this can vary depending on your treatment plan. Each session typically lasts no more than 20 minutes from where the radioactive material is in position.

Meanwhile, low-dose rate brachytherapy is typically implanted in a single procedure that takes less than a day but gives off radiation for a few months.

In most cases, you can go home after treatment, although there are some cases where it might be safer to remain for observation for a few nights.

As with other types of radiotherapy treatment, however, you will need someone to take you to and from the hospital due to the anaesthetic used for treatment.

Radioactivity After Treatment

One question that is sometimes asked regarding brachytherapy regards radioactivity following treatment, and whether any precautions need to be made before and after treatment.

The answer depends on the type of treatment, as you are only radioactive whilst a source of radiation is inside your body.

You will be treated in a room on your own and may not be able to have visitors if you need to stay as an inpatient, depending on the types of treatment you had.

If you have radioactive seeds implanted, you will be radioactive, although only close to the treatment area.

You are typically safe to be around most people, but you may be advised to avoid holding children or being in close contact with pregnant women as a precaution. They can remain in the same room as you, but hugging or holding them for more than a few minutes may need to be avoided.

Whilst the radioactive seeds will remain in your body forever, the radiation itself will fade after a few weeks or months. As it does, you will no longer need to be careful with close contact.

Are There Any More Precautions To Take After Treatment?

You will receive medications to help ease any symptoms and receive a card with contact details and an explanation of the treatment you have had.

For the first few days after treatment, the area where you had treatment may feel sore, and you will need to avoid intense exercise and heavy lifting for at least three days.

Make sure to stay hydrated, eat a balanced diet and take any pain medication that you have been prescribed.

The symptoms will get easier after the first few weeks, and you will have regular follow-up sessions to ensure that if there are any unexpected issues that they can be addressed by your doctor and multidisciplinary team.

Amethyst Healthcare Acquired by Fremman

Amethyst Healthcare Group Enters Growth Chapter with Acquisition by Fremman Capital

Amethyst Radiotherapy Group (“Amethyst”), a leading pan-European provider of cancer care services, today announced that it has entered into an agreement to be acquired by Fremman Capital, a pan-European mid-market private equity firm. This strategic partnership marks a significant milestone in Amethyst’s journey and sets the stage for accelerated expansion and innovation across the European oncology landscape.

Founded in 2010, Amethyst has become one of the largest independent radiotherapy providers in Europe. Operating 19 cutting-edge cancer treatment centers across France, Poland, Romania, the UK, Italy, and Austria, Amethyst treats more than 50,000 patients annually. The Group delivers a comprehensive suite of oncology services — primarily radiotherapy — through a dedicated team of over 500 healthcare professionals and in collaboration with nearly 100 partner physicians.

As part of the transaction, Fremman Capital will acquire a majority stake in Amethyst, while the company’s founding shareholders and The Rohatyn Group will fully exit their investment. Fremman brings deep experience in healthcare and a strong track record of scaling essential service providers across Europe, making them a natural partner to support Amethyst’s long-term vision.

This partnership with Fremman marks a new era of opportunity for Amethyst,” said Stéphane Carré, CEO of Amethyst Radiotherapy Group.

“Their expertise in healthcare and long-term investment philosophy aligns perfectly with our mission: to deliver advanced, accessible cancer care to more people, in more places. With their support, we will continue investing in cutting-edge technologies, expanding our footprint both organically and through partnerships and M&A, making a difference in the lives of patients and families across Europe.”

 

Amethyst has built a strong reputation for clinical excellence, operating nearly 40 state-of-the-art linear accelerators — the primary technology used in modern radiotherapy — and forming long-standing partnerships with public health systems to ensure the equitable delivery of life-saving care.

The radiotherapy market continues to show strong growth, driven by rising cancer incidence and increasing recognition of radiotherapy as a highly effective, non-invasive treatment option with minimal side effects. Fremman’s investment underscores the strength of Amethyst’s model and its leadership position in this critical area of cancer care.

The transaction is expected to close in the coming months, subject to customary regulatory approvals.

 


About Amethyst Radiotherapy
Amethyst is a leading European cancer care provider specialising in radiotherapy, chemotherapy, and diagnostic imaging. With operations in six countries and 19 centers, Amethyst combines clinical excellence with patient-centered care to improve access to oncology treatment across Europe. The Group partners closely with public healthcare systems, delivering services under reimbursement-based models.

About Fremman

Fremman Capital is a pan-European, mid-market investment firm with offices in London, Luxembourg, Paris, Madrid, and Munich. The firm partners with ambitious management teams to help transform businesses into multinational sustainable leaders, particularly in sectors essential to society such as healthcare, technology, and business services.

For more information: www.fremman.com

Media Contact:
Sophie Ward
Email Address: [email protected]
Phone Number: +44 208 713 0460
Organisation Website: www.amethysthealthcare.com